Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Journal of Drugs in Dermatology : JDD|August 2, 2024
Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque PsoriasisJayme Heim, J Gabriel Vasquez, Tina Bhutani, et al.The Journal of Clinical and Aesthetic Dermatology|April 21, 2025
Efficacy and Safety of Fixed-dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Black Participants with Moderate to Severe AcneValerie D Callender, Andrew F Alexis, Neal Bhatia, et al.Heart Rhythm|March 4, 2024
Evaluation of the in vivo chemical reactivity of a novel copolymer insulation on cardiac leads in a single-center studyRand Ibrahim, Kimberly Chaffin, Anand Shah, et al.Journal of Drugs in Dermatology : JDD|March 5, 2015
Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscapeTheodore Rosen, Sheila Fallon Friedlander, Leon Kircik, et al.Physiological Reports|January 9, 2014
Posttranslational regulation of tissue inhibitor of metalloproteinase-1 by calcium-dependent vesicular exocytosisJonathan A Dranoff, Neal Bhatia, Michel Fausther, et al.The Journal of Clinical and Aesthetic Dermatology|October 24, 2024
Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled TrialsLawrence J Green, Hilary Baldwin, Jeffrey Sugarman, et al.European Cardiology|October 13, 2018
Current Treatment of Familial HypercholesterolaemiaCameron T Lambert, Pratik Sandesara, Ijeoma Isiadinso, et al.The Journal of Dermatological Treatment|June 21, 2023
Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trialsZoe D Draelos, Emil A Tanghetti, Leon H Kircik, et al.Journal of Drugs in Dermatology : JDD|July 30, 2020
Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/EthnicityNeal Bhatia, Jonathan S Weiss, Neil Sadick, et al.Journal of Drugs in Dermatology : JDD|April 2, 2024
Efficacy and Tolerability of Topical 0.1% Stabilized Bioactive Retinol for Photoaging: A Vehicle-Controlled Integrated AnalysisPatricia Farris, Diane Berson, Neal Bhatia, et al.Pageof 11